Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 234,264,602 papers from all fields of science
Search
Sign In
Create Free Account
MS 932
Known as:
MS-932
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Broader (1)
4-(acetylamino)benzeneacetic acid
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
1990
1990
Immunopharmacological studies of 4-acetylaminophenylacetic acid (MS-932)
Y. Nakagawa
,
T. Ogawa
,
+7 authors
N. Ishida
1990
Corpus ID: 77833746
1990
1990
Suppressive effect of 4-acetylaminophenylacetic acid (MS-932) on delayed-type hypersensitivity in mice
Y. Nakagawa
,
T. Ogawa
,
K. Umezu
,
Y. Shibata
,
H. Fujisawa
,
S. Sato
1990
Corpus ID: 57931287
1990
1990
Characterization of suppressor cells activated by 4-acetylaminophenylacetic acid (MS-932) in delayed-type hypersensitivity
Y. Nakagawa
,
T. Ogawa
,
K. Umezu
,
Y. Shibata
,
T. Nishimura
,
S. Sato
1990
Corpus ID: 79242282
1990
1990
Pharmacokinetics of 4-acetylaminophenylacetic acid. 1st communication: absorption, distribution, metabolism and excretion in mice, rats, dogs and monkeys after single administration of 14C-labeled…
K. Sugihara
,
A. Morino
,
A. Nomura
,
S. Iida
,
M. Sugiyama
Arzneimittel-Forschung
1990
Corpus ID: 42511934
Absorption, distribution, metabolism and excretion of 4-acetylaminophenylacetic acid (MS-932) were studied in mice, rats, dogs…
Expand
1988
1988
Effect of MS-932 (4-acetylaminophenylacetic acid on delayed-type hypersensitivity reaction induced by the influenza virus A) Kumamoto haemagglutinin in cyclophosphamide-treated mice
T. Nishimura
,
C. Abe
,
S. Hirose
,
Y. Shibata
,
S. Sato
1988
Corpus ID: 77759969
1987
1987
Effect of MS-932 (4-acetylaminophenylacetic acid) on articular lesions in MRL/I mice
H. Yoshida
,
H. Fujisawa
,
C. Abe
,
Y. Shibata
,
S. Sato
,
Y. Shiokawa
1987
Corpus ID: 79097993
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE